August 25, 2016 09:06 AM EDTUpdated September 18, 06:22 PM
Startups
R&D
News Briefing

Pro­to­cols: BeiGene signs up Medi­va­tion’s Amy Pe­ter­son as its new CMO; Ac­ne drug de­vel­op­er files for $60M IPO

John Carroll

Editor & Founder

Now that Pfiz­er has bagged Medi­va­tion in its $14 bil­lion buy­out deal, the scram­ble for top tal­ent has be­gun. Chi­na’s BeiGene was one of the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

Bris­tol My­ers sues the fed­er­al gov­ern­ment over 340B, fol­low­ing oth­er drug­mak­ers

A service from the Financial Times